SCHEMBL20242579

SCHEMBL20242579

COc1cc(N)ccc1[C@@H]1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 8/20 0.57
NR1H2 P55055 1/20 0.47
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
STS P08842 1/20 0.44
HTT P42858 1/20 0.44
USP30 Q70CQ3 1/20 0.43
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
PIK3CD O00329 2/20 0.42
PIK3CA P42336 2/20 0.42
PIK3CB P42338 2/20 0.42
PIK3CG P48736 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20260763 1.00 PDE4B (0.57) PDE4BNR1H2ALDH1A1MEN1KMT2A
SCHEMBL282618 0.93 PDE4B (0.51) PDE4BNR1H2ALDH1A1MEN1KMT2A
SCHEMBL31257859 0.93 PDE4B (0.51) PDE4BNR1H2ALDH1A1MEN1KMT2A
SCHEMBL1015417 0.86 PDE4B (0.57) PDE4BALDH1A1MEN1KMT2AKDM4E
SCHEMBL1014743 0.86 PDE4B (0.57) PDE4BALDH1A1MEN1KMT2AKDM4E
SCHEMBL1015416 0.86 PDE4B (0.57) PDE4BALDH1A1MEN1KMT2AKDM4E
SCHEMBL1018705 0.86 PDE4B (0.57) PDE4BALDH1A1MEN1KMT2AKDM4E
SCHEMBL30962613 0.86 NR1H2 (0.49) PDE4BNR1H2ALDH1A1MEN1KMT2A
SCHEMBL15785400 0.85 GPR119 (0.49) PDE4BNR1H2KDM4EMAPTTHRB
SCHEMBL5515302 0.84 PDE4B (0.53) PDE4BNR1H2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106646-A1 AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed